Skip to main content
. 2021 Apr 7;13(4):e14344. doi: 10.7759/cureus.14344

Table 1. Baseline characteristics of patients who survived compared to those who died undergoing transcatheter aortic valve intervention.

CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease; PVD, peripheral vascular disease

Univariate analysis  Died during hospitalization Multivariate analysis, OR (95% CI)
Variable (%) No (211,319) Yes (4,664) Survived versus died
Age, median (IQR) 82 (75-87) 83 (77-88) -
Female 98,131 (46.4%) 2,514 (53.9%) 0.74 (0.65-0.84) (reference to males)
White 175,097 (87.0%) 3,815 (86.6%) Reference to whites
Black 8,468 (4.2%) 125 (2.8%) 0.8 (0.56-1.17)
Hispanics 9,362 (4.6%) 265 (6.0%) 0.54 (0.32-0.93)
Alcohol 722 (0.3%) 15 (0.3%) 0.3 (0.18-0.51)
Coagulopathy 28,616 (13.5%) 1,414 (30.3%) 5.827 (5.18-6.56)
CAD 145,538 (68.9%) 2,794 (59.9%) 0.76 (0.71-0.81)
CHF 155,292 (73.5%) 3,694 (79.2%) 1.315 (1.22-1.42)
COPD 70,788 (33.5%) 1,843 (39.5%) 1.216 (1.14-1.29)
CVD 24,603 (11.6%) 866 (18.6%) 1.74 (1.61-1.88)
Diabetes 26,880 (12.7%) 250 (5.4%) 0.5 (0.44-0.57)
Hypertension 184,336 (87.2%) 3,360 (72.0%) 0.44 (0.41-0.47)
Liver disease 6,280 (3.0%) 750 (16.1%) 5.09 (4.65-5.57)
End-stage renal Disease 7,893 (3.7%) 310 (6.6%) 1.55 (1.37-1.76)
Obesity 28,920 (13.7%) 285 (6.1%) 0.49 (0.44-0.56)
PVD 47,494 (22.5%) 1,375 (29.5%) 1.39 (1.31-1.49)
Weight loss 7,217 (3.4%) 665 (14.3%) 3.02 (2.75-3.31)
Anemia 63,871 (30.2%) 1,564 (33.5%) 0.89 (0.84-0.95)
Thrombocytopenia 29,686 (14.0%) 1,065 (22.8%) 0.29 (0.26-0.34)
Colorectal cancer 340 (0.2%) 0 (0.0%) -
Breast cancer 635 (0.3%) 5 (0.1%) 0.42 (0.17-1.02)
Lung cancer 780 (0.4%) 25 (0.5%) 1.56 (1.04-2.33)
Atrial fibrillation 87,361 (41.3%) 2,201 (47.2%) 1.18 (1.12-1.26)
Income
0-25th percentile 44,256 (21.3%) 984 (21.6%) Reference to 0-25th percentile
25th–50th 52,967 (25.5%) 1,075 (23.6%) 0.96 (0.79-1.15)
50th-75th 55,224 (26.5%) 1,210 (26.5%) 0.87 (0.73-1.05)
75th-100th 55,648 (26.7%) 1,295 (28.4%) 0.94 (0.79-1.13)
Length of stay, median (IQR) 3 (2-6) 7 (2-16) -
Cost of stay, median (IQR) 180,644 (133,645-257,922.8) 309,412 (208,125-455,263) -